How to Conduct Healthcare and Pharmaceutical Research for Reliable, Decision-Ready Evidence

Healthcare research conducted with weak screening or an unsuitable methodology can produce evidence that fails to reflect the target audience or the decision at hand. Once the study starts from the wrong foundation, every conclusion becomes harder to trust.

If you do not want your project to become another example of failed healthcare research, you need a structured process from the initial decision to the final action. This guide explains how to conduct healthcare and pharmaceutical market research in 8 practical steps, covering respondent selection, screening, methodology, question design, data quality, analysis, and decision use.

Start by defining the decision that the research needs to support. A strong research brief answers two questions: what needs to be designed and what healthcare research needs to validate before the team moves forward.

For example, instead of setting a broad objective such as “understand patient opinions”, a pharmaceutical team can define the decision more clearly: “We need to design a patient support program for diagnosed patients who stop treatment early. Research needs to validate why patients discontinue therapy, which support formats feel useful, and which communication moments influence continuation".

Before selecting respondents, you need to map the decision pathway behind the research. The right audience is not chosen from broad labels such as patients or HCPs. It is chosen by looking at who experiences the issue, who influences the decision, who controls access, and who uses the product in real settings.

Once the audience map is clear, respondent verification should be adapted by audience type. Patients may need to be verified by diagnosis or treatment history. HCPs may need checks around specialty. Payers, pharmacists, caregivers, and healthcare administrators each require different verification logic based on how they influence the healthcare decision.

Start with the decision area from Step 1, then trace the pathway around it.

A strong screener is one of the most important parts of healthcare and pharmaceutical research. Broad labels such as “patient”, “doctor”, or “healthcare consumer” are not enough. The study needs respondents with the right condition, experience, role, and decision relevance.

To build a stronger screener, you should screen in 4 layers:

For HCP studies, TGM understands that respondent relevance needs careful validation from the beginning. Before moving into deeper checks such as professional background, the first step is to clarify who the study actually needs to reach.

The table below helps define the HCP profile, so the research team can screen for professionals who are truly relevant to the study objective.

Healthcare research needs the right methodology because each decision requires a different type of evidence.

In practice, many healthcare studies use a mixed-method design. Qualitative research explains why a barrier exists, while quantitative research measures how common or important that barrier is.

Healthcare question design requires extra care because unclear wording can lead respondents to misread the question and choose the wrong answer.

At TGM, we believe every healthcare question needs to balance medical accuracy with respondent clarity.

• Patients need plain language: “medicine you take every day” instead of “chronic maintenance therapy”
• HCPs need clinical precision: line of therapy, contraindication, treatment switching, or clinical endpoint may be appropriate when the respondent is qualified.
• Payers need value and access language: budget impact, comparative value, reimbursement barrier, formulary inclusion.
• Pharmacists need recommendation and substitution language: “What would you recommend if the consumer asks for X symptom?”

Healthcare survey wording should be reviewed by people who understand both research design and the healthcare context. A specialist research partner can help check terminology, respondent logic, sensitive wording, and data quality risks before fieldwork begins. If your team plans to run a DIY healthcare survey, review every question carefully before launching.

Before launching the survey, it is useful to review what not to ask. Phrases such as “Why did you fail…”, “Don’t you think…”, “Would you use this because it works better…”, “This product is safe and effective”, or “Did the drug cause…” can create biased answers. The safer approach is to use neutral wording that lets respondents describe their real experience without pressure.

These examples show why healthcare survey wording needs careful review before fieldwork. A small wording issue can change how respondents answer, and that can affect product claims, treatment behavior analysis, HCP confidence, and market access decisions.

Before launching, you also use a simple DIY check:

• Can the target respondent understand the question without guessing?
• Does the wording match the respondent’s medical knowledge level?
• Do the answer choices reflect real healthcare behavior?
• Does the question avoid blame, medical advice, and unsupported claims?
• Is there a clear process for sensitive safety-related comments?

Public resources can support this review, especially when you need to check clarity, patient-facing wording, and safety-related processes:

• FDA patient labeling resources: Useful for developing patient-facing prescription drug information.
• FDA Patient Medication Information: Helps focus on essential and understandable information for patients.
• CDC Clear Communication Index: Provides research-based criteria for reviewing public health communication materials.
• EPHMRA adverse event reporting guidance: Supports you in managing adverse events, special reporting situations, and product complaints.

Healthcare studies attract false qualification because niche respondents are harder to recruit. Quality controls need to include consistency checks, speed checks, attention checks, open-end review, duplicate detection, and behavioral monitoring.

Healthcare analysis needs more than age, gender, and income. Strong research analysis includes treatment stage, condition severity, care access, provider relationship, insurance situation, trust level, digital readiness, and country-specific healthcare behavior.

The final output needs to guide decisions. Useful findings inform product design, patient support, clinical communication, payer strategy, market entry, segmentation, pricing, channel planning, and launch strategy.

Healthcare market research needs clear ethical and privacy controls because participants often share sensitive information about their health or treatment experience. Requirements need to be defined before fieldwork so recruitment, consent, data handling, and reporting follow the study scope and applicable market rules.

Informed consent

Participants need to understand what they are agreeing to before taking part. Consent information needs to explain:

• The purpose of the research
• What participation involves
• How their data will be used
• Their right to stop participating

The wording needs to match the audience. Patient-facing consent should use clear language, while professional studies need enough detail to explain the research context without creating unnecessary complexity.

Personal and health data protection

Sensitive healthcare data needs to be handled according to the requirements that apply to the study and market.

Depending on the project, these requirements include GDPR, local privacy laws, sponsor policies, or client-specific data handling standards. You need to define what data is collected, where it is stored, who has access, and how long it is retained before fieldwork begins.

Adverse event and product complaint handling

Pharmaceutical research needs a documented process for identifying and forwarding possible adverse events or product complaints when the study scope requires it.

Responsibilities need to be agreed before launch between the research team, sponsor, and other relevant parties. The process depends on the study design and applicable regulations, so one reporting procedure does not apply universally across every healthcare project.

Respondent confidentiality

Participant information needs to be protected throughout recruitment, fieldwork, and reporting.

Collect only the information required for the research objective, restrict access to authorized teams, and use anonymization or pseudonymization where appropriate. Data transfers also need secure handling, while reporting should generally present findings at an aggregated level unless the study requires another approved format.

Research with vulnerable groups

Studies with children, people with cognitive impairments, severely ill patients, or other vulnerable populations require additional safeguards.

The research design needs to consider consent capacity, respondent burden, sensitive wording, and appropriate support from caregivers or legal representatives. Recruitment methods and incentives also need careful review so participation remains voluntary and respectful.

Local market requirements

Healthcare research requirements differ across countries, so multi-market studies need local compliance checks before fieldwork begins.

Local rules affect areas such as recruitment eligibility, respondent incentives, consent materials, and data handling. Keeping the research framework consistent while adapting execution to each market helps protect both compliance and cross-market comparability.

In reality, healthcare and pharmaceutical research requires external partner support because the execution risk is higher than in general consumer research. The real challenge is reaching qualified respondents, protecting sensitive data, screening niche audiences, and controlling fieldwork quality across markets.

If you decide to work with a research partner, you still need to understand the 5 five steps clearly: the decision, respondent groups, screener logic, methodology choice, and question design. Then, you also need an overall view of the next steps, including data quality control, healthcare-context analysis, and action planning.

The guide below clarifies what you need to own, what research partners need to manage, and how both sides work together to produce reliable healthcare research outcomes.

Healthcare organizations need to own the strategic, medical, and compliance direction of the research.

• First, define the business or care decision behind the project. Research becomes more useful when it links directly to a launch, reimbursement plan, patient program, communication strategy, product design decision, or market entry move.
• Second, define the target respondents precisely. A patient sample needs clear condition and treatment criteria. An HCP sample needs specialty, decision role, care setting, and clinical experience criteria. A payer sample needs the right reimbursement or access perspective.
• Third, review terminology, product claims, and clinical logic. Poorly defined treatment categories or unclear health terms produce misleading responses.
• Fourth, confirm privacy boundaries, consent language, sensitive data handling, and internal review requirements. EPHMRA’s Code of Conduct provides ethical and legal guidance for multi-country healthcare market research, including pharmaceutical drugs, biologics, medical devices, and diagnostics.
• Fifth, prepare market context for the research partner. Care pathways, reimbursement systems, pharmacy access, hospital procurement, and patient behavior differ by country. Local context helps the study avoid generic conclusions.
• Finally, turn insights into responsible action. Market research supports strategy, communication, product development, and commercial planning. It does not replace clinical judgment, regulatory review, or medical evidence.

Healthcare organizations need a specialist research partner because healthcare fieldwork is harder to execute than standard consumer research.

A strong healthcare research partner is responsible for:

• Reaching qualified healthcare audiences: Many studies require niche profiles such as diagnosed patients, caregivers, specialist physicians, pharmacists, payers, or users of a specific treatment category. Standard consumer sampling rarely provides enough precision for these groups.
• Validating respondent eligibility: Healthcare studies face higher false-qualification risk because qualified respondents are harder to find. Strong screening logic, profile checks, duplicate controls, and response quality monitoring protect the reliability of the data.
• Managing complex fieldwork execution: Multi-country healthcare studies require quota control, survey localization, timeline management, and consistent execution across markets.
• Protecting privacy and respondent sensitivity: Healthcare respondents often share information related to diagnosis, treatment history, care access, insurance status, or caregiving roles. A research partner needs clear consent, secure handling, anonymized reporting, and careful respondent management.
• Adapting research to local healthcare context: Healthcare behavior differs by market. Pharmacy influence, doctor-patient relationships, insurance models, and digital health trust can change how respondents answer and how findings should be interpreted.

A strong research process needs more than a well-written questionnaire. TGM Research helps connect the healthcare decision with qualified respondents, appropriate methodology, and controlled fieldwork execution.

TGM supports your study through:

• Research objective clarification: Connect the study scope with the product, patient, access, communication, or market decision that requires evidence.
• Healthcare audience feasibility: Assess access to defined patients, caregivers, HCPs, pharmacists, payers, and other specialist audiences across 130+ markets.
• Respondent screening support: Develop qualification criteria around condition, treatment experience, professional specialty, recent exposure, and decision involvement.
• Sample-Only or Full-Service execution: Provide respondent access for internal research teams or broader support covering questionnaire setup, recruitment, data collection, and project coordination.
• Multi-market fieldwork management: Maintain consistent respondent definitions while adapting terminology and healthcare context by country.
• Data quality protection: TGM Research Shield applies fraud detection, duplicate controls, behavioral monitoring, consistency checks, and open-ended response review.
• Compliance-aware processes: Support clear consent, privacy-conscious respondent handling, secure fieldwork documentation, and alignment with client-specific adverse event procedures.